Clinical Ophthalmology
Volume 13, 2019 - Issue
Open access
130
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies
Raymond Fong1 Manhattan Eye, Ear and Throat Hospital and Lenox Hill Hospital, New York, NY, USA
, Megan E Cavet2 Medical Affairs, Bausch + Lomb, Rochester, NY, USA
, Heleen H DeCory2 Medical Affairs, Bausch + Lomb, Rochester, NY, USACorrespondence[email protected]
& Jason L Vittitow3 Clinical Affairs, Bausch + Lomb, Bridgewater, NJ, USA
Pages 1427-1438
|
Published online: 01 Aug 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.